Sign Up Today and Learn More About Ensoma Stock
Invest in or calculate the value of your shares in Ensoma or other pre-IPO companies through EquityZen's platform.
Ensoma Stock (ENSO)
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
About Ensoma Stock
Founded
2019
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Ensoma Press Mentions
Stay in the know about the latest news on Ensoma
Ensoma Appoints Accomplished Deal Maker Jon Garen as Chief Corporate Development and Business Officer
businesswire • Oct 28, 2024
Ensoma shutters Copenhagen site from its Twelve Bio acquisition
endpts • Oct 01, 2024
Ensoma next stop for company builder Jim Burns
thepharmaletter • Jun 25, 2024
Jim Burns reunites with Genzyme colleague at Ensoma; Lilly exec to retire after 27 years
sdbn • May 24, 2024
Ensoma next stop for company builder Jim Burns
thepharmaletter • May 13, 2024
Ensoma Management
Leadership team at Ensoma
Board of Directors
Kouki Harasaki
Chief Operating Officer
Min Wang
Join now and verify your accreditation status to gain access to:
- Ensoma current valuation
- Ensoma stock price
- Available deals in Ensoma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Ensoma stock?
Accredited investors can buy pre-IPO stock in companies like Ensoma through EquityZen funds. These investments are made available by existing Ensoma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ensoma stock?
Shareholders can sell their Ensoma stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
